Skip to main content
RYTM logo

RYTM · Rhythm Pharmaceuticals, Inc. · Analyst Estimates

Track RYTM — free
$95.22 -0.50 (-0.52%) At close · Sep 30
Market Cap
$6.79B
Shares
68.85M
Volume · Sep 30 737.18K Avg daily vol (3M) 650.29K

Analyst Estimates

Compare analyst forecasts for Rhythm Pharmaceuticals, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 08:13 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.36
-3.1004
-2.82217
—
-3.06994
-3.23576
-3.07456
-3.25758
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
2
2
6
7
Revenue
USD
Publication date not stated
298500000
313297120
336400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.45026
-0.6126
0.53
—
-0.61143
-0.73237
-0.61427
-0.74137
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
5
4
3
4
Revenue
USD
Publication date not stated
460000000
558339800
645990740
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
18
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.85
-0.76369
-0.66504
—
-0.75269
-0.82123
-0.75369
-0.82668
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
3
3
5
6
Revenue
USD
Publication date not stated
78000000
83678930
93000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.93
-0.75137
-0.58
—
-0.73039
-0.7845
-0.73554
-0.8005
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
2
4
5
5
Revenue
USD
Publication date not stated
89000000
97842940
112000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
16
— — — — — — — —
Key facts CIK 1649904 CUSIP 76243J105 13F (30d) 9 filings 9 filers Visit website Investor relations